Hayek Medical, a division of United Hayek Industries specializes in the design, manufacture and sale of non-invasive respiratory devices, in particular using a new and patented method of ventilation to achieve what is known as Biphasic Cuirass Ventilation (BCV). We are the world leader in this relatively new and unique method of ventilation.
BCV has been proven to work and be extremely effective for a wide variety of patient groups: neuromuscular, COPD, cystic fibrosis, and ARDS patients amongst many others. There have been over 300 publications supporting this method published to date.
BCV can be applied in the hospital and/or home, during a pandemic, man-made, and natural crisis. Biphasic Cuirass Ventilation does not always require skilled medical professionals during, and almost anyone can apply BCV to a patient with minimal training. BCV minimizes risks and complications, leading to significantly better patient outcomes during emergencies, including pandemics.